04.06.2018 23:21:00

/C O R R E C T I O N -- BD (Becton, Dickinson and Company)/

In the news release, BD to Present at Investor Healthcare Conferences, issued June 1, 2018 by BD (Becton, Dickinson and Company) over PR Newswire, we are advised by the company that the Goldman Sachs 38th Annual Global Healthcare Conference time should read "11:40 a.m. EDT" rather than "8:40 a.m. EDT" as originally issued inadvertently. The complete, corrected release follows:

BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J., June 1, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences:

Jefferies 2018 Global Healthcare Conference
June 8, 2018
10:00 a.m. EDT

Goldman Sachs 38th Annual Global Healthcare Conference
June 13, 2018
11:40 a.m. EDT

Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors.  They will be available for replay for a period of seven days after each conference.  

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visitbd.com.

Contact:
Kristen Cardillo, Communications – 858-847-5657
Monique Dolecki, Investor Relations - 201-847-5378

 

Cision View original content:http://www.prnewswire.com/news-releases/bd-to-present-at-investor-healthcare-conferences-300658358.html

SOURCE BD (Becton, Dickinson and Company)

Analysen zu Becton, Dickinson & Co. (BD)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Becton, Dickinson & Co. (BD) 209,60 -0,24% Becton, Dickinson & Co. (BD)